Active & Upcoming Opportunities
Federally-funded research and technology development collaborations represent great business opportunities for those in academia and industry, especially small and emerging companies that have not traditionally worked with the government in the past. The below lists include current and upcoming solicitations encompassing a wide range of programs and technology areas.
CWMD: CBRN Sensor Integration on Robotic Platforms, CSIRP, Capability Set, CS 4.0
Anticipated Release Date: Q4FY25
MCDC: Vaccines Capability Area
Anticipated Release Date: Q3FY24 or Q4FY24
CWMD: Agent Directed Therapeutic (ADTX) FY25 OTA
Anticipated Release Date: Q1FY25
CWMD: Diagnostic Platforms for Agnostictoxin Detections
Anticipated Release Date: Q2FY25
CWMD: Capabilities and Needs for Future Respiratory and Ocular Protection Systems
Anticipated Release Date: Q3FY25
CWMD: Synthetic binder prediction, synthesis, and assay development
Anticipated Release Date: Q3FY25
CWMD: Biocontainment Isolation System – Enhanced Biodefense, BCIS-ENBD
Anticipated Release Date: Q3FY25
CWMD: Portable Patient Transport System – Enhanced Biodefense, PPTS-ENBD
Anticipated Release Date: Q3FY25
CWMD: Shipboard Isolation System (SIS)
Anticipated Release Date: Q3FY25
MCDC: Consolidated Nerve Agent Treatment System
Anticipated Release Date: Q1FY25
CWMD: CIND, All States of Matters for Various Chemical Hazards
Anticipated Release Date: Q4FY25
CWMD: Far Forward Biological Sequencing, FFBS, Increment 2
Anticipated Release Date: Q1FY26
CWMD: Advanced System for Protection and Integrated Reduction of Encumbrances, ASPIRE
Anticipated Release Date: Q3FY26
CWMD: Advanced Differential Diagnostics, ADD
Anticipated Release Date: Q4FY27
MCDC: Accelerated Antibodies Modification
Anticipated Release Date: Q3FY24
MCDC: Development of Novel, Broad Spectrum Countermeasures, and enabling capabilities for Toxin Exposure
Anticipated Release Date: Q4FY24
MCDC: Prototype MCMs to address the therapeutic indications of the Warfighter exposure to viral and bacterial biothreat agents.
Anticipated Release Date: Q4FY24
MCDC: Development of alternate large animal models for biothreats (viral and toxin) and chemical threats
Anticipated Release Date: Q4FY24
AMTC: GM-24-11-01 Indirect Fire Protection Capability 2nd Interceptor
Submission Deadline: 10/22/2024
MTEC: Platelet and Platelet-like Products State of the Technology Meeting Request for Information
Submission Deadline: 11/01/2024 12PM ET
DIBC: RWP KIN-24-03, Critical Chemicals for Defense
Submission Deadline: 11/06/2024 5PM ET
CWX: PPO-CWX-004-GDO: OSW Transmission Standardization Consortia
Submission Deadline: 11/01/2024 5PM ET
CWMD: RPP 24-08 Handheld Spectrometer System Prototype for Waveguide-Enhanced Raman Spectroscopy
Submission Deadline: 10/15/2024 12PM ET
MCDC: RPP-2024-01 Commercialization
Submission Deadline: 10/18/2024 12PM ET
CWMD: RPP 24-01 Commercialization
Submission Deadline: 10/18/2024 12PM ET
RRPV: RPP 24-02-OralVx
Submission Deadline: 11/01/2024 1PM ET
NSTIC: Digital Proving Ground Three Dimensional Passive Sensing
Submission Deadline: 10/09/2024
AMTC: Weapons and Protective Technologies Process Improvement Prototype (WPTPIP)
Submission Deadline: 09/30/2024 1PM ET
TREXII: Improved Modular Fuel Delivery Station (iMFDS) Prototype Development and Testing
Submission Deadline: 10/30/2024
TREXII: Improved Modular Fuel Delivery Station (iMFDS) Prototype Development and Testing
Submission Deadline: 10/30/2024 12PM ET
CWMD: Portable Patient Transport System – Enhanced Biodefense (PPTS-ENBD) / PPMT
Anticipated Release Date: Q4FY24
CWMD: Autonomous Decontamination System (ADS) / PPMT
Anticipated Release Date: Q1FY25
CWMD: Shipboard Isolation System (SIS) / PPMT
Anticipated Release Date: Q4FY24
CWMD: VADER VaporAgent Demasking – Easily Readable
Anticipated Release Date: Q2FY25
CWMD: SInISTER, Systems Integrating innovative Solutions, Detection Technologies
Anticipated Release Date: Q2FY25
CWMD: Novelbioaerosol Detection and Identification Technologies
Anticipated Release Date: Q2FY25
MCDC: Therapeutics Capability Area
Anticipated Release Date: Q3FY24 OR Q4FY24
MCDC: Mature Microphysiological System (MPS) to directly compare to well-characterized animal model results
Anticipated Release Date: Q4FY24
Award Process
Where the magic happens!
What sets our process apart from others is robust collaboration between government and solution providers before requirements are released. This meaningful engagement speeds the process, because the need has been well-defined and industry/academia have a strong understanding of the problem the government needs solved. ATI helps the government refine their requirements through this facilitated collaboration.
Our government customers need the best ideas to choose from.
ATI supports the government to develop a streamlined, repeatable solicitation process, and then trains the members so they are prepared to respond. We advertise solicitation opportunities broadly, do targeted recruitment, and create an environment where the right teams come together to respond with their best ideas. ATI hosts secure portals for submissions and government evaluations.
ATI is a force multiplier for the acquisition community.
Our large in-house team of contracting professionals speaks the language of non-traditionals, helping them navigate every step of the award process. Our team ensures all required proposal information has been supplied, performs an initial analysis to speed the government review process, and negotiates when needed based on government parameters. Once awarded, ATI supports contractual and financial administration, so the government can focus on technology development.